ResearcherIstituto Mediterraneo per i Trapianti e Terapie ad Alta SpecializzazioneActive in the last 2 years

Mario Traina

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5041-0858; OpenAlex author ID A5055913589. Sources: ClinicalTrials.gov.

Their work

Papers: 1
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 trial

Papers 1

EUS-guided radiofrequency ablation of small pancreatic adenocarcinoma: a new therapeutic option for patients unfit for surgery. Co-author DOI 10.1016/j.vgie.2018.09.008 ↗

Trials 1

Graphic Novel for Patients Undergoing EUS-FNB Study director NCT06268106 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ilaria Tarantino · 1 shared paper, 1 shared trial, 2019–2024 · strength 0.67
- Trial Graphic Novel for Patients Undergoing EUS-FNB NCT06268106 ↗
- Paper EUS-guided radiofrequency ablation of small pancreatic adenocarcinoma: a new therapeutic option for patients unfit for … DOI 10.1016/j.vgie.2018.09.008 ↗
Giacomo Emanuele Maria Rizzo · 1 shared trial, 2024 · strength 0.54
- Trial Graphic Novel for Patients Undergoing EUS-FNB NCT06268106 ↗
Dario Ligresti · 1 shared paper, 2019 · strength 0.12
- Paper EUS-guided radiofrequency ablation of small pancreatic adenocarcinoma: a new therapeutic option for patients unfit for … DOI 10.1016/j.vgie.2018.09.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.